康众医疗
(688607)
| 流通市值：54.74亿 | | | 总市值：60.81亿 |
| 流通股本：7932.90万 | | | 总股本：8812.90万 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 68,538,444.85 | 320,858,788.25 | 226,019,950.4 | 144,883,131.24 |
| 营业收入 | 68,538,444.85 | 320,858,788.25 | 226,019,950.4 | 144,883,131.24 |
| 二、营业总成本 | 84,939,925.27 | 312,536,140.52 | 220,453,690.46 | 138,664,445.91 |
| 营业成本 | 44,211,276.39 | 203,295,902.44 | 140,058,440.66 | 88,525,970.48 |
| 税金及附加 | 563,534.97 | 1,142,210.66 | 846,200.99 | 661,273.22 |
| 销售费用 | 7,745,052.96 | 31,509,842.81 | 24,868,504.67 | 17,055,556.02 |
| 管理费用 | 16,982,537.23 | 36,847,011.12 | 26,528,398.32 | 16,855,697.52 |
| 研发费用 | 8,959,968.59 | 32,054,265.91 | 23,852,161.81 | 15,473,515.2 |
| 财务费用 | 6,477,555.13 | 7,686,907.58 | 4,299,984.01 | 92,433.47 |
| 其中:利息费用 | 118,432.68 | 950,250.29 | 712,479.91 | 298,318.76 |
| 其中:利息收入 | -28,831 | 675,779.44 | 434,848.32 | 367,355.12 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 179,013.7 | 2,251,205.92 | -310,122.25 | -313,217 |
| 加:投资收益 | -1,397,392.81 | 941,705.16 | 917,627.65 | 821,072.79 |
| 资产处置收益 | - | 147,888.49 | 5,515.14 | 5,515.14 |
| 资产减值损失(新) | -139,768.24 | -7,511,901.06 | -1,611,025.96 | 85,757.17 |
| 信用减值损失(新) | 461,336.69 | -17,499,896.84 | -8,514,844.18 | -8,766,781.95 |
| 其他收益 | 676,158.74 | 3,981,271.13 | 2,555,656.53 | 1,292,029.48 |
| 四、营业利润 | -16,622,132.34 | -9,367,079.47 | -1,390,933.13 | -656,939.04 |
| 加:营业外收入 | 1,111.06 | 259,788.18 | 61,708.97 | 61,304.91 |
| 减:营业外支出 | 160,979.13 | 377,455.08 | 213,010.64 | 121,922.38 |
| 五、利润总额 | -16,782,000.41 | -9,484,746.37 | -1,542,234.8 | -717,556.51 |
| 减:所得税费用 | 218,140.19 | -2,155,772 | -1,652,421.8 | -38,731.7 |
| 六、净利润 | -17,000,140.6 | -7,328,974.37 | 110,187 | -678,824.81 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -17,000,140.6 | -7,328,974.37 | 110,187 | -678,824.81 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -16,205,231.69 | -6,666,847.52 | 347,982.91 | -739,398.63 |
| 少数股东损益 | -794,908.91 | -662,126.85 | -237,795.91 | 60,573.82 |
| 扣除非经常损益后的净利润 | -16,378,905.98 | -16,915,923.31 | -4,348,248.63 | -3,390,000.27 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.19 | -0.08 | 0 | -0.01 |
| (二)稀释每股收益 | -0.19 | -0.08 | 0 | -0.01 |
| 八、其他综合收益 | -2,503,930.71 | 3,813,586.37 | 368,662.76 | 422,207.56 |
| 归属于母公司股东的其他综合收益 | -2,488,852.76 | 3,780,298.1 | 364,800.21 | 428,106.31 |
| 九、综合收益总额 | -19,473,915.41 | -3,515,388 | 471,124.66 | -256,617.25 |
| 归属于母公司股东的综合收益总额 | -18,694,084.45 | -2,886,549.42 | 712,783.12 | -311,292.32 |
| 归属于少数股东的综合收益总额 | -779,830.96 | -628,838.58 | -241,658.46 | 54,675.07 |
| 公告日期 | 2026-04-25 | 2026-04-25 | 2025-10-23 | 2025-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |